HCPCS Code J0582

Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
Code effective Oct 01, 2025

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J0582 is a valid 2026 HCPCS code meaning Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg or (Bivalirudin (endo) 1 mg) for short. HCPCS J0582 has been effective since 10/01/2025 and applies to Medical care.


HCPCS Code Details - J0582

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J0582
Description

Long description:
Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg

Short description:
Bivalirudin (endo) 1 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Oct 01, 2025
Date added Added Oct 01, 2025

See also

  • HCPCS J0578 · Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy

  • HCPCS J0583 · Injection, bivalirudin, 1 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.